Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 2, Issue 1, 2010, Pages

  Marzano, Alfredo ^a   Marengo, Andrea ^a   di Fonzo, Michela ^b   Begini, Paola ^b   Ferrari, Antonella ^b   Monarca, Bruno ^b   delle Fave, Gianfranco ^b   Marignani, Massimo ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; BILIRUBIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; GLUCOCORTICOID; HEPATITIS B SURFACE ANTIGEN; IFOSFAMIDE; LAMIVUDINE; MESNA; MITOXANTRONE; PREDNISOLONE; RITUXIMAB; VIRUS DNA;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLICULAR LYMPHOMA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERSENSITIVITY; IMMUNOREGULATION; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LEUKEMIA REMISSION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER INJURY; MALE; MYELOID LEUKEMIA; VIRUS REACTIVATION;

EID: 79952804485     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2010.035     Document Type: Article

References (12)

1. Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 2007; 39: 397-408. doi:10.1016/j.dld.2006.12.017.
2. Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically-mediated liver disease. Gastroenterology 2001; 120: 1009-22. doi:10.1053/gast.2001.22461.
3. Fujiwara K, Yokosuka O, Kojima H, Kanda T, Saisho H, Hirasawa H, Suzuki H. Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B. World J Gastroenterol 2005; 11: 1109-14.
4. Fujiwara K, Yasui S, Yonemitsu Y, Fukai K, Arai M, Imazeki F, Suzuki A, Sadahiro T, Oda S, Yokosuka O. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B. J Gastroenterol; 2008; 43: 711-19. doi: 10.1007/s00535-008-2222-5.
5. Tillmann HL, Wedemeyer H, Manns MP. Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation. J Hepatol 2003; 39 Suppl 1): S206-11. doi:10.1016/S0168-8278(03)00364-7.
6. Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology 2006; 43: 209-220. doi:10.1002/hep.21051.
7. Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2009; 27:605-11. doi:10.1200/JCO.2008.18.0182.
8. Niitsu N, Hagiwara Y, Tanae K, Kohri M, Takahashi N. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotheraphy. J Clin Oncol 2010 Sept 13. [Epub ahead of print].
9. Tsubota A, Arase Y, Suzuki Y, Suzuki F, Sezaki H, Hosaka T, Akuta N, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2005; 20: 426-32. doi:10.1111/j.1440-1746.2004.03534.x.
10. Chan HL, Tsang SW, Hui Y, Leung NW, Chan FK, Sung JJ. The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice. J Viral Hepat 2002; 9: 424-8. doi:10.1046/j.1365-2893.2002.00385.x.
11. Tornatore KM, Venuto RC, Logue G, Davis PJ. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure. J Med 1998; 29: 159-83.
12. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hepatitis B virus DNA contains glucocorticoid-reponsive element. Proc Natl Acad Sci USA 1986; 83: 1627-31. doi:10.1073/pnas.83.6.1627